Article
Genetic and immunologic studies of patients on procainamide.
Human immunology - 1 Mar 1998
Adams L E, Balakrishnan K, Malik S, Mongey A B, Whitacre L, Hess E V
Abstract excerpt
Forty (40) patients with cardiac arrhythmias receiving procainamide (PA) therapy and 24 patients who were receiving other drugs for their cardiac disorders were investigated for class II HLA phenotypes and their DRB1*04 and DQB1*03 subtypes. Other genetic marker evaluations in the PA patients included: 1) class III MHC C4A and C4B null alleles of complement; and, 2) acetylation phenotype. Twenty (20) of the PA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.